Bio-Rad to Participate in the Bank of America Merrill Lynch Health Care Conference 2019 in May

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice President and CFO, will participate in the Bank of America Merrill Lynch Health Care Conference 2019 on May 14, at 10:40 AM Pacific Time, at the Encore Hotel, Las Vegas, Nevada.

A link to the live audio webcast of the Fireside Chat will be available in the Investor Relations area of our website at www.bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018. For more information, please visit www.bio-rad.com.

Bio-Rad Laboratories, Inc.
Tina Cuccia, Corporate Communications
510-724-7000
[email protected]